Everything that happened today

on

Article Digest Summary

Event
subject: As omicron variant is detected around the world, travel bans may be too late, experts say
Event
subject: COVID-19 may be causing diabetes among some severely infected patients, studies find
Event
subject: Suspected case confirmed: Omicron variant has arrived in Hesse, Germany
Event
subject: Update on Omicron
Event
subject: World Health Organization reaches draft consensus on future pandemic treaty
Event
subject: University in Afghanistan's Kandahar holds graduation ceremony (Men and Women) - in Pictures
Event
subject: WHO says it is not yet clear if Omicron causes more severe disease
Event
subject: 5 people wounded in Aurora shooting
Event
subject: 'Absolute chaos' in South Africa as flights grounded over Omicron
Event
subject: Once rare, lung transplants for COVID-19 patients are rising quickly
Event
subject: 2 cases of omicron variant confirmed in Ottawa, Ontario government says | CBC News
Event
subject: 40 passengers to Dubai produce fake COVID certificate; held at CSMIA
Event
subject: 'He walked on the bus and began shooting,' 3 shot, 1 dead after gunman opens fire
Event
subject: Covid: South Africa 'punished' for detecting new Omicron variant
Event
subject: Pfizer Antiviral Drug May Be 90% Effective Against COVID-19
Event
subject: U.S. readies fight against Omicron but too soon for lockdowns -Fauci
Event
subject: Omicron variant now in North America, Canadian officials say
Event
subject: Austria's Covid Surge Is a Warning to the World
Event
subject: Michael Cohen says Trump won't pursue a 2024 White House bid, calls his 'Big Lie' fundraising appeals 'the greatest grift in US history'
Event
subject: Anti-vax zealot may face charges after death of Covid-19 patient
Event
subject: Canada's first cases of the omicron coronavirus variant confirmed in Ottawa
Event
body:

On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE).  This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes. Here is a summary of what is currently known.  

 

Current knowledge about Omicron 

Researchers in South Africa and around the world are conducting studies to better understand many aspects of Omicron and will continue to share the findings of these studies as they become available.  

Transmissibility: It is not yet clear whether Omicron is more transmissible (e.g., more easily spread from person to person) compared to other variants, including Delta. The number of people testing positive has risen in areas of South Africa affected by this variant, but epidemiologic studies are underway to understand if it is because of Omicron or other factors.  

Severity of disease: It is not yet clear whether infection with Omicron causes more severe disease compared to infections with other variants, including Delta.  Preliminary data suggests that there are increasing rates of hospitalization in South Africa, but this may be due to increasing overall numbers of people becoming infected, rather than a result of specific infection with Omicron.  There is currently no information to suggest that symptoms associated with Omicron are different from those from other variants.  Initial reported infections were among university students—younger individuals who tend to have more mild disease—but understanding the level of severity of the Omicron variant will take days to several weeks.  All variants of COVID-19, including the Delta variant that is dominant worldwide, can cause severe disease or death, in particular for the most vulnerable people, and thus prevention is always key. 

 

Effectiveness of prior SARS-CoV-2 infection 

Preliminary evidence suggests there may be an increased risk of reinfection with Omicron (ie, people who have previously had COVID-19 could become reinfected more easily with Omicron), as compared to other variants of concern, but information is limited. More information on this will become available in the coming days and weeks. 

Effectiveness of vaccines: WHO is working with technical partners to understand the potential impact of this variant on our existing countermeasures, including vaccines. Vaccines remain critical to reducing severe disease and death, including against the dominant circulating variant, Delta. Current vaccines remain effective against severe disease and death.   

Effectiveness of current tests: The widely used PCR tests continue to detect infection, including infection with Omicron, as we have seen with other variants as well. Studies are ongoing to determine whether there is any impact on other types of tests, including rapid antigen detection tests.  

Effectiveness of current treatments:   Corticosteroids and IL6 Receptor Blockers will still be effective for managing patients with severe COVID-19. Other treatments will be assessed to see if they are still as effective given the changes to parts of the virus in the Omicron variant.  

 

Studies underway 

At the present time, WHO is coordinating with a large number of researchers around the world to better understand Omicron. Studies currently underway or underway shortly include assessments of transmissibility, severity of infection (including symptoms), performance of vaccines and diagnostic tests, and effectiveness of treatments.    

WHO encourages countries to contribute the collection and sharing of hospitalized patient data through the WHO COVID-19 Clinical Data Platform to rapidly describe clinical characteristics and patient outcomes.  

More information will emerge in the coming days and weeks. WHO's TAG-VE will continue to monitor and evaluate the data as it becomes available and assess how mutations in Omicron alter the behaviour of the virus.  

 

Recommended actions for countries 

As Omicron has been designated a Variant of Concern, there are several actions WHO recommends countries to undertake, including enhancing surveillance and sequencing of cases;  sharing genome sequences on publicly available databases, such as GISAID; reporting initial cases or clusters to WHO; performing field investigations and laboratory assessments to better understand if Omicron has different transmission or disease characteristics, or impacts effectiveness of vaccines, therapeutics, diagnostics or public health and social measures.  More detail in the announcement from 26 November.  

Countries should continue to implement the effective public health measures to reduce COVID-19 circulation overall, using a risk analysis and science-based approach. They should increase some public health and medical capacities to manage an increase in cases.  WHO is providing countries with support and guidance for both readiness and response.  

In addition, it is vitally important that inequities in access to COVID-19 vaccines are urgently addressed to ensure that vulnerable groups everywhere, including health workers and older persons, receive their first and second doses, alongside equitable access to treatment and diagnostics.  

 

Recommended actions for people 

The most effective steps individuals can take to reduce the spread of the COVID-19 virus is to keep a physical distance of at least 1 metre from others; wear a well-fitting mask; open windows to improve ventilation; avoid poorly ventilated or crowded spaces; keep hands clean; cough or sneeze into a bent elbow or tissue; and get vaccinated when it's their turn.  

WHO will continue to provide updates as more information becomes available, including following meetings of the TAG-VE. In addition, information will be available on WHO's digital and social media platforms. 

 

Reference material:  

 

 

 



On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO's Technical Advisory Group on Virus Evolution (TAG-VE).  This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes. Here is a summary of what is currently known.  

 

Current knowledge about Omicron 

Researchers in South Africa and around the world are conducting studies to better understand many aspects of Omicron and will continue to share the findings of these studies as they become available.  

Transmissibility: It is not yet clear whether Omicron is more transmissible (e.g., more easily spread from person to person) compared to other variants, including Delta. The number of people testing positive has risen in areas of South Africa affected by this variant, but epidemiologic studies are underway to understand if it is because of Omicron or other factors.  

Severity of disease: It is not yet clear whether infection with Omicron causes more severe disease compared to infections with other variants, including Delta.  Preliminary data suggests that there are increasing rates of hospitalization in South Africa, but this may be due to increasing overall numbers of people becoming infected, rather than a result of specific infection with Omicron.  There is currently no information to suggest that symptoms associated with Omicron are different from those from other variants.  Initial reported infections were among university students—younger individuals who tend to have more mild disease—but understanding the level of severity of the Omicron variant will take days to several weeks.  All variants of COVID-19, including the Delta variant that is dominant worldwide, can cause severe disease or death, in particular for the most vulnerable people, and thus prevention is always key. 

 

Effectiveness of prior SARS-CoV-2 infection 

Preliminary evidence suggests there may be an increased risk of reinfection with Omicron (ie, people who have previously had COVID-19 could become reinfected more easily with Omicron), as compared to other variants of concern, but information is limited. More information on this will become available in the coming days and weeks. 

Effectiveness of vaccines: WHO is working with technical partners to understand the potential impact of this variant on our existing countermeasures, including vaccines. Vaccines remain critical to reducing severe disease and death, including against the dominant circulating variant, Delta. Current vaccines remain effective against severe disease and death.   

Effectiveness of current tests: The widely used PCR tests continue to detect infection, including infection with Omicron, as we have seen with other variants as well. Studies are ongoing to determine whether there is any impact on other types of tests, including rapid antigen detection tests.  

Effectiveness of current treatments:   Corticosteroids and IL6 Receptor Blockers will still be effective for managing patients with severe COVID-19. Other treatments will be assessed to see if they are still as effective given the changes to parts of the virus in the Omicron variant.  

 

Studies underway 

At the present time, WHO is coordinating with a large number of researchers around the world to better understand Omicron. Studies currently underway or underway shortly include assessments of transmissibility, severity of infection (including symptoms), performance of vaccines and diagnostic tests, and effectiveness of treatments.    

WHO encourages countries to contribute the collection and sharing of hospitalized patient data through the WHO COVID-19 Clinical Data Platform to rapidly describe clinical characteristics and patient outcomes.  

More information will emerge in the coming days and weeks. WHO's TAG-VE will continue to monitor and evaluate the data as it becomes available and assess how mutations in Omicron alter the behaviour of the virus.  

 

Recommended actions for countries 

As Omicron has been designated a Variant of Concern, there are several actions WHO recommends countries to undertake, including enhancing surveillance and sequencing of cases;  sharing genome sequences on publicly available databases, such as GISAID; reporting initial cases or clusters to WHO; performing field investigations and laboratory assessments to better understand if Omicron has different transmission or disease characteristics, or impacts effectiveness of vaccines, therapeutics, diagnostics or public health and social measures.  More detail in the announcement from 26 November.  

Countries should continue to implement the effective public health measures to reduce COVID-19 circulation overall, using a risk analysis and science-based approach. They should increase some public health and medical capacities to manage an increase in cases.  WHO is providing countries with support and guidance for both readiness and response.  

In addition, it is vitally important that inequities in access to COVID-19 vaccines are urgently addressed to ensure that vulnerable groups everywhere, including health workers and older persons, receive their first and second doses, alongside equitable access to treatment and diagnostics.  

 

Recommended actions for people 

The most effective steps individuals can take to reduce the spread of the COVID-19 virus is to keep a physical distance of at least 1 metre from others; wear a well-fitting mask; open windows to improve ventilation; avoid poorly ventilated or crowded spaces; keep hands clean; cough or sneeze into a bent elbow or tissue; and get vaccinated when it's their turn.  

WHO will continue to provide updates as more information becomes available, including following meetings of the TAG-VE. In addition, information will be available on WHO's digital and social media platforms. 

 

Reference material:  

 

 

 

subject: Update on Omicron
Event
subject: Dutch police arrest couple that fled COVID quarantine
Event
subject: Scientists are studying whether Omicron leads to severe illness.
Event
subject: Covid: South Africa calls for lifting of Omicron travel bans
Event
subject: Ghislane Maxwell trial... Why isn't the media talking about it more?
Event
subject: Covid-struck Czech President appoints new Prime Minister from inside a glass box
Event
subject: American vaccine disinformation used as 'Trojan horse' for far right in New Zealand
Event
subject: Australia's reopening plans in doubt after Omicron cases
Event
subject: Australian government's 'anti-troll' legislation to unmask online trolls
Event
subject: "One Thing We Have Learned Is that COVID Is an Asshole". Doctors and nurses at the intensive care ward in Leipzig University Hospital are fighting desperately to save the lives of corona truthers. It can be a thankless task.
Event
subject: Omicron variant spreads to North America, Australia and more of Europe
Event
subject: Ghislaine Maxwell's sex-trafficking trial to begin in New York City
Event
subject: Safe and alive, but 'traumatized,' the future of these Afghan women footballers is very uncertain
Event
subject: Quebec City police caught violently arresting Black youth: video
Event
subject: Gottlieb says Omicron variant of COVID-19 "almost definitely" already in U.S.
Event
subject: 14-year-old boy charged with the murder of 12-year-old Ava White.
Event
subject: U.S. does not impose new Omicron testing for passengers from southern Africa
Event
subject: Omicron poses "very high" global risk, countries must prepare - WHO
Event
subject: Morocco suspends all incoming flights over Omicron
Event
subject: Queensland woman who ran down and killed cyclist in 'sheer rage' jailed for 10 years | Queensland
Event
subject: Six cases of Omicron variant identified in Scotland
Event
subject: Country where 54 percent of adults drink alcohol once a week may run out of liquor for Christmas
Event
subject: Fauci: US could face 'fifth wave' of Covid as Omicron variant nears
Event
subject: First 13 cases of Omicron in Portugal identified, all in the football team B SAD
Event
subject: Scotland reports six Omicron cases, some not linked to travel
Event
subject: Couple caught fleeing Dutch COVID-19 quarantine moved to "forced isolation"
Event
subject: NSW police officer allegedly lied to court to support then-girlfriend's false rape claim
Event
subject: Twitter CEO Jack Dorsey is expected to step down, sources say
Event
subject: State of Victoria to host biggest wind farm in southern hemisphere as turbines win final approval
Event
subject: Canada calls for international pandemic treaty and emergency summit, second of its kind in history
Event
subject: Leading breeder of beagles for research slammed by animal welfare inspectors
Event
subject: California town declares itself a 'constitutional republic' to buck Covid rules
Event
subject: Sweden's first female PM returns after resignation
Event
subject: U.S. to Expel More Russian Diplomats, Moscow Says - The Moscow Times
Event
subject: COVID-19 Burnout Prompting US Nurses to Quit, Leaving Patients in Danger
Event
subject: Omicron Variant Drives Rise in Covid-19 Hospitalizations in South Africa Hot Spot
Event
subject: Former FBI Director James Comey's daughter is a lead prosecutor in Ghislaine Maxwell's child sex trafficking case
Event
subject: The Toll of NYCHA's Lead Lies: A Brooklyn Girl Poisoned as Officials Covered Up Danger
Event
subject: NYC reinstitutes Covid mask advisory 'at all times' indoors regardless of vaccination status
Event
subject: U.S. Gives Rwanda Nearly 2 Million COVID-19 Vaccine Doses in Total
Event
subject: Portugal finds 13 Omicron cases at top-division football club
Event
subject: Jussie Smollett: Jury selection begins in actor's trial

Comments

Post a Comment